Pharmacovigilance and Clinical Safety: Comparison between India, US and Europe-A Review
Received Date: Apr 01, 2023 / Accepted Date: Apr 27, 2023 / Published Date: Apr 28, 2023
Abstract
Pharmacovigilance (PV) is a crucial component of the system for regulating pharmaceuticals. PV is essential for the detection, evaluation, and dissemination of adverse drug reactions (ADRs) using a variety of channels. ADRs cause significant harm to patients and can possibly increase morbidity and mortality. The public health safety and promotion of responsible drug use are both aided by the PV databases. In order to broaden the scope of the current PV structure in India, this essay analyzes the PV systems in the USA, Europe, and India while underlining the difficulties and potential solutions. In comparison to other nations, PV schemes in India are still in their infancy.
Citation: Tom A, Joseph R, Pingat P, Harinarayanan (2023) Pharmacovigilanceand Clinical Safety: Comparison between India, US and Europe-A Review. Int JRes Dev Pharm L Sci, 9: 151.
Copyright: © 2023 Tom A, et al. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 914
- [From(publication date): 0-2023 - May 20, 2024]
- Breakdown by view type
- HTML page views: 802
- PDF downloads: 112
